➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Medtronic
Express Scripts
Merck
Baxter

Last Updated: April 22, 2021

DrugPatentWatch Database Preview

LORAZEPAM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Lorazepam, and what generic alternatives are available?

Lorazepam is a drug marketed by Amneal Pharms, Hi-tech Pharma Co, Lannett Co Inc, Lupin Ltd, Pharm Assoc, Akorn, Bedford, Dava Pharms Inc, Dr Reddys, Hospira, Intl Medication Sys, Mylan Asi, Watson Labs, West-ward Pharms Int, Roxane, Am Therap, Anda Repository, Ani Pharms Inc, Aurolife Pharma Llc, Halsey, Leading Pharma Llc, Mutual Pharm, Mylan, Oxford Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, Warner Chilcott, Hikma, and Bedford Labs. and is included in sixty-four NDAs.

The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lorazepam

A generic version of LORAZEPAM was approved as lorazepam by SANDOZ on April 21st, 1987.

  Get Started Free

Drug patent expirations by year for LORAZEPAM
Drug Prices for LORAZEPAM

See drug prices for LORAZEPAM

Drug Sales Revenue Trends for LORAZEPAM

See drug sales revenues for LORAZEPAM

Recent Clinical Trials for LORAZEPAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Drug Abuse (NIDA)Phase 2
InterveXion Therapeutics, LLCPhase 2
Jayasree BasivireddyPhase 3

See all LORAZEPAM clinical trials

Pharmacology for LORAZEPAM
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for LORAZEPAM

US Patents and Regulatory Information for LORAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz LORAZEPAM lorazepam TABLET;ORAL 071193-001 Apr 15, 1988 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Anda Repository LORAZEPAM lorazepam TABLET;ORAL 072555-002 Mar 29, 1991 DISCN No No   Get Started Free   Get Started Free   Get Started Free
West-ward Pharms Int LORAZEPAM lorazepam INJECTABLE;INJECTION 074496-001 Sep 28, 1998 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Warner Chilcott LORAZEPAM lorazepam TABLET;ORAL 071039-001 Jan 12, 1988 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Aurolife Pharma Llc LORAZEPAM lorazepam TABLET;ORAL 203572-003 Dec 22, 2017 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Mylan LORAZEPAM lorazepam TABLET;ORAL 077657-001 Mar 16, 2006 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Ani Pharms Inc LORAZEPAM lorazepam TABLET;ORAL 077396-002 Dec 13, 2006 DISCN No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Medtronic
McKinsey
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.